Search results
Results from the WOW.Com Content Network
Cryopreservation of ovarian tissue is of interest to women who want fertility preservation beyond the natural limit, or whose reproductive potential is threatened by cancer therapy, [1] for example in hematologic malignancies or breast cancer. [2]
Women with a family history of early menopause may have an interest in fertility preservation to preserve viable eggs that could deteriorate at an earlier onset. Those with ovarian diseases such as Polycystic Ovary Syndrome could opt for this method. [citation needed] Oocyte cryopreservation is one of many options for individuals undergoing IVF ...
Surgical extraction of ovarian tissue for cryopreservation. [25] Can be carried out before and after puberty. [24] No sperm necessary at time of retrieval. [25] Clinically available. [25] Don't need to halt GAHT. [24] Cryopreservation of either an ovarian cortex biopsy or the whole ovary, then the thawing and maturation of the follicles at a ...
A tank of liquid nitrogen, used to supply a cryogenic freezer (for storing laboratory samples at a temperature of about −150 °C or −238 °F) Controlled-rate and slow freezing, also known as slow programmable freezing (SPF), [18] is a technique where cells are cooled to around -196 °C over the course of several hours.
Ovarian tissue cryopreservation also poses a risk of reintroducing malignant cells after cancer recovery, particular in those with previous leukaemia. [1] Artificial ovaries could be an effective alternative in fertility preservation. The artificial ovary aims to replicate its natural counterpart by producing oocytes and releasing steroid hormones.
The therapy, Elahere, was being tested in patients with a type of cancer that affects the ovaries, fallopian tube or walls of the abdomen, and who have received at least two prior lines of treatment.
A group of scientists has devised a plan to safeguard Earth’s species in a cryogenic biorepository on the moon. These scientists want to safeguard Earth’s species by cryogenically preserving ...
TVOR is typically performed after ovarian hyperstimulation, where oocytes are pharmacologically stimulated to mature. When the ovarian follicles have reached a certain degree of development, induction of final oocyte maturation is performed, generally by an intramuscular or subcutaneous injection of human chorionic gonadotropin (hCG). [10]